Article From: ""   Read full article

By Chuck Tanowitz
Working with recombinant DNA — the technology used in making insulin and other biologic drugs — is common in the biotech and pharmaceutical
world. So much so, that it’s now more difficult to find a lab that doesn’t work in rDNA than finding one that does.
Last year, the Town of Needham obtained a Gold BioReady rating from the state, certifying that it has biotech and life sciences-friendly zoning (a
streamlined permitting process) and has robust infrastructure in place.
Companies looking for lab space use those rankings to help guide their decisions about where to